These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 20187206
1. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K. J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206 [Abstract] [Full Text] [Related]
2. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S. J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633 [Abstract] [Full Text] [Related]
3. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M. Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184 [Abstract] [Full Text] [Related]
4. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Chen M, Dang HD, Wang JY, Zhou C, Li SY, Wang WC, Zhao WF, Yang ZH, Zhong CY, Li GZ. Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549 [Abstract] [Full Text] [Related]
5. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience. Kim CK, Park BK, Park W, Kim SS. Abdom Imaging; 2010 Apr; 35(2):246-52. PubMed ID: 19130116 [Abstract] [Full Text] [Related]
6. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology. Selnæs KM, Heerschap A, Jensen LR, Tessem MB, Schweder GJ, Goa PE, Viset T, Angelsen A, Gribbestad IS. Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187 [Abstract] [Full Text] [Related]
7. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. Xu PJ, Yan FH, Wang JH, Lin J, Ji Y. J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186 [Abstract] [Full Text] [Related]
8. Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging? Iwazawa J, Mitani T, Sassa S, Ohue S. Diagn Interv Radiol; 2011 Sep; 17(3):243-8. PubMed ID: 20859852 [Abstract] [Full Text] [Related]
9. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. Vilanova JC, Barceló-Vidal C, Comet J, Boada M, Barceló J, Ferrer J, Albanell J. AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259 [Abstract] [Full Text] [Related]
10. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization. Kim JK, Hong SS, Choi YJ, Park SH, Ahn H, Kim CS, Cho KS. J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542 [Abstract] [Full Text] [Related]
11. Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI. Ueno Y, Kitajima K, Sugimura K, Kawakami F, Miyake H, Obara M, Takahashi S. J Magn Reson Imaging; 2013 Jul; 38(1):154-60. PubMed ID: 23292979 [Abstract] [Full Text] [Related]
12. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ. J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216 [Abstract] [Full Text] [Related]
13. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results. Kim CK, Choi D, Park BK, Kwon GY, Lim HK. J Magn Reson Imaging; 2008 Oct; 28(4):963-9. PubMed ID: 18821631 [Abstract] [Full Text] [Related]
14. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. Kim CK, Park BK, Lee HM. J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194 [Abstract] [Full Text] [Related]
15. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Kim CK, Park BK, Lee HM, Kwon GY. Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156 [Abstract] [Full Text] [Related]
16. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging. Tamada T, Sone T, Higashi H, Jo Y, Yamamoto A, Kanki A, Ito K. AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809 [Abstract] [Full Text] [Related]
17. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H. J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357 [Abstract] [Full Text] [Related]
18. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate. Baur AD, Maxeiner A, Franiel T, Kilic E, Huppertz A, Schwenke C, Hamm B, Durmus T. Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440 [Abstract] [Full Text] [Related]
19. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps. Sung YS, Kwon HJ, Park BW, Cho G, Lee CK, Cho KS, Kim JK. AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504 [Abstract] [Full Text] [Related]
20. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion. Nishie A, Stolpen AH, Obuchi M, Kuehn DM, Dagit A, Andresen K. J Magn Reson Imaging; 2008 Sep; 28(3):705-13. PubMed ID: 18777555 [Abstract] [Full Text] [Related] Page: [Next] [New Search]